>If IFN lambda had the same efficacy as IFN Alpha, without the side effects,(and was approved by the fda today) how would that change the current landscape?<
If that were the case, there would be no reason for anyone to use ifn-alpha. Moreover, a higher proportion of the individuals with chronic HCV would seek treatment than the proportion who seek treatment today.
Market Data 
Markets 
AI
